Home
Therapeutic Areas
Epithelial Tumors of the Prostate
Mesenchymal Tumors
Prostatic Adenocarcinoma
Neuroendocrine Prostate Cancer (NEPC)
Castration-Resistant Prostate Cancer (CRPC)
Prostate Cancer Models
In Vitro
Model
Prostate Cancer Cell Lines
Prostate Cancer Spheroids
Prostate Cancer Organoids
Scaffold-based Systems
Tissue Slices Models
Tumor-on-a-chip
In Vivo
Model
Humanized Model
Genetically Engineered Model
Spontaneous Tumor Model
Chemically Induced Model
Syngeneic Model
Cell Line-Derived Xenograft (CDX) Model
Patient-Derived Xenograft (PDX) Model
Metastatic Tumor Model
Disseminated Tumor Model
Subcutaneous Tumor Model
Orthotopic Tumor Model
Drug Discovery
By Target
AR Signaling Axis Inhibitor
PI3K/AKT/mTOR Pathway Inhibitor
Epigenetic Modulator
Prostate Cancer Growth Modulator
Other Therapeutic Target Modulator
PARP Inhibitor Development
CDK4/6 Inhibitor Development
p53 Inhibitor Development
PSMA-targeted Therapy Development
Immune Checkpoint Inhibitor Development
WNT Inhibitor Development
VEGF Inhibitor Development
TGFβ Inhibitor Development
NRTKs Inhibitor Development
MEK/ERK Inhibitor Development
By Molecule Type
Small Molecule Drug
Proteolysis Targeting Chimeras Development Service
Molecular Glue Degrader Development Service
Small Molecule Drug Conjugate Development Service
Therapeutic Antibody
Monoclonal Antibody Development Service
Polyclonal Antibody Development Service
Bispecific Antibody Development Service
Single Domain Antibody Development Service
ADC Development Service
ATC Development Service
Cell Therapy
CAR-T Cell Therapy Development for Prostate Cancer
CAR-NK Cell Therapy Development for Prostate Cancer
TCR-T Therapy Development for Prostate Cancer
TIL Therapy Development for Prostate Cancer
TAM Therapy Development for Prostate Cancer
T-DC Therapy Development for Prostate Cancer
APC-based Therapy Development Service
CSC Therapy Development for Prostate Cancer
Gene Therapy
DNA-based Gene Therapy Development for Prostate Cancer
RNA-based Gene Therapy Development for Prostate Cancer
Therapeutic Vaccine
Peptide/protein Vaccine Development for Prostate Cancer
DNA Vaccine Development for Prostate Cancer
mRNA Vaccine Development for Prostate Cancer
Bacterial Vaccine Development Service
Adenovirus Vaccine Development Service
Dendritic Cell Vaccine Development for Prostate Cancer
Oncolytic Viral Therapy
RDC Development
Combination Therapy
R&D Services
Diagnostic Development
Biomarker Discovery
Omics Analysis
HRD Gene Detection
Preclinical Drug Development
Drug Discovery
Efficacy Evaluation
DMPK/ADME
Safety Assessment
Clinical Research Services
Investigator Initiated Trial (IIT) Services
Industry Sponsored Trial (IST) Services
Phase I Clinical Trial
Phase II Clinical Trial
Phase III Clinical Trial
Phase IV Clinical Trial
Medical & Clinical Strategy Services
IND/NDA/BLA Application Strategy Services
Medical Writing Services
Site Management & Patient Recruitment Services
Data Management & Statistical Analysis Services
Medical Monitoring Services
Safety & Pharmacovigilance Services
Quality Management Services
Project Management Services
Post-Marketing Study Services
Resources
Company
About Us
Contact Us
Careers
×
Drug Discovery
Home
Drug Discovery
Solutions
By Target
AR Signaling Axis Inhibitor
PI3K/AKT/mTOR Pathway Inhibitor
Epigenetic Modulator
Prostate Cancer Growth Modulator
Other Therapeutic Target Modulator
PARP Inhibitor Development
CDK4/6 Inhibitor Development
p53 Inhibitor Development
PSMA-targeted Therapy Development
Immune Checkpoint Inhibitor Development
WNT Inhibitor Development
VEGF Inhibitor Development
TGFβ Inhibitor Development
NRTKs Inhibitor Development
MEK/ERK Inhibitor Development
By Molecule Type
Small Molecule Drug
Proteolysis Targeting Chimeras Development Service
Molecular Glue Degrader Development Service
Small Molecule Drug Conjugate Development Service
Therapeutic Antibody
Monoclonal Antibody Development Service
Polyclonal Antibody Development Service
Bispecific Antibody Development Service
Single Domain Antibody Development Service
ADC Development Service
ATC Development Service
Cell Therapy
CAR-T Cell Therapy Development for Prostate Cancer
CAR-NK Cell Therapy Development for Prostate Cancer
TCR-T Therapy Development for Prostate Cancer
TIL Therapy Development for Prostate Cancer
TAM Therapy Development for Prostate Cancer
T-DC Therapy Development for Prostate Cancer
APC-based Therapy Development Service
CSC Therapy Development for Prostate Cancer
Gene Therapy
DNA-based Gene Therapy Development for Prostate Cancer
RNA-based Gene Therapy Development for Prostate Cancer
Therapeutic Vaccine
Peptide/protein Vaccine Development for Prostate Cancer
DNA Vaccine Development for Prostate Cancer
mRNA Vaccine Development for Prostate Cancer
Bacterial Vaccine Development Service
Adenovirus Vaccine Development Service
Dendritic Cell Vaccine Development for Prostate Cancer
Oncolytic Viral Therapy
RDC Development
Combination Therapy
Online Inquiry
Name *
Email *
Phone *
Services Interested *
Project Description
Please note that we are not a pharmacy or clinic, so we are unable to see patients and do not offer diagnostic and treatment services for individuals.
Submit
For research use only
For research use only
For research use only